01 4ALFACALCIDOL
02 1AMPHOTERICIN B
03 2BUDESONIDE
04 2BUSERELIN (BUSERELIN ACETATE)
05 7CANDESARTAN CILEXETIL
06 2CAPECITABINE
07 2CILAZAPRIL (CILAZAPRIL MONOHYDRATE)
08 7CLONAZEPAM
09 1Calcium carbonate; Cholecalciferol
10 6Candesartan cilexetil
11 4Candesartan cilexetil; Hydrochlorothiazide
12 2Capecitabine
13 2Carvedilol
14 2Clomethiazole
15 1DEXAMETHASONE (DEXAMETHASONE SODIUM METASULPHOBENZOATE)
16 1DISOPYRAMIDE
17 1ETOPOSIDE
18 1ETOPOSIDE PHOSPHATE
19 1FRAMYCETIN SULFATE
20 2Flumazenil
21 1GANCICLOVIR (GANCICLOVIR SODIUM)
22 1GANCICLOVIR SODIUM
23 1GRAMICIDIN
24 4HYDROCHLOROTHIAZIDE
25 5HYDROXYUREA
26 1Manidipine
27 11OLANZAPINE
28 3OLANZAPINE PAMOATE
29 1OMEPRAZOLE
30 1OMEPRAZOLE (OMEPRAZOLE MAGNESIUM)
31 2ORLISTAT
32 14Olanzapine
33 3Olanzapine embonate monohydrate
34 6Omeprazole
35 1Orlistat
36 3Pioglitazone
37 1Pioglitazone; Metformin
38 10Quetiapine
39 1Sotalol
40 3Spironolactone
41 2TRETINOIN
42 1Ticlopidine
43 1Tretinoin
44 4Ursodeoxycholic Acid
45 4Ursodeoxycholic acid
46 2VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE)
47 2VALGANCICLOVIR HYDROCHLORIDE
48 1VERTEPORFIN
49 1Valganciclovir
50 1clomethiazole
51 1klometiazoledisilat
01 33CHEPLAPHARM
02 89CHEPLAPHARM ARZNEIMITTEL GMBH
03 5CHEPLAPHARM REGISTRATION GMBH
04 12CHEPLAPHARM Registration GmbH
05 3Cheplapharm Arzneimittel GmbH
06 2Cheplapharm Arznemittel GmbH
01 7CAPSULE
02 1CAPSULE (DELAYED RELEASE)
03 6CAPSULE;ORAL
04 1Capsule, soft
05 2Coated Tablets
06 4DROPS
07 2Extended Release Hard Capsules
08 4Extended Release Tablets
09 1Extended Release Tablets 60 Tablets
10 1FOR SOLUTION;ORAL
11 12Film-Coated Tablets
12 1Flumazenil 0.5Mg 5Ml 1 Units Parenteral Use
13 1Flumazenil 1Mg 10Ml 1 Units Parenteral Use
14 4Gastro-Resistant Hard Capsules
15 2Hard Capsules
16 1IMPLANT
17 2INJECTABLE;INJECTION
18 1INJECTABLE;INTRAMUSCULAR
19 1Kapsel, hard
20 4Melting tablet
21 2Modified-Release Hard Capsules
22 1ORAL SOLUTION
23 2Orodispersible Tablets
24 4POWDER FOR SOLUTION
25 2POWDER, METERED;INHALATION
26 1Potion, resolution
27 3Powder and liquid for depot injection, suspension
28 1Powder for solution for injection
29 1SOFT CAPSULE
30 2SOLUTION
31 3SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
32 1Spironolactone 100Mg 10 Units Oral Use
33 1Spironolactone 25Mg 16 Combined Oral Use
34 16TABLET
35 1TABLET (DELAYED-RELEASE)
36 4TABLET, ORALLY DISINTEGRATING;ORAL
37 14TABLET;ORAL
38 2Tablet
39 4Tablet, coated
40 14Tablets
41 2Tablets 28 Tablets
42 1Tretinoin 10Mg 100 Unita' Oral Use
43 1Ursodeoxycholic Acid 150Mg 20 Joined' Oral Use
44 1Ursodeoxycholic Acid 225Mg 20 Joined' Oral Use
45 1Ursodeoxycholic Acid 300Mg 20 Joined' Oral Use
46 1Ursodeoxycholic Acid 450Mg 20 Joined' Oral Use
01 10.05MG/ML
02 10.08MG/INH
03 10.125MG
04 10.16MG/INH
05 10.25MCG
06 10.25MG
07 20.5MG
08 10.5MG/ML
09 11 ampoule EV 0.5 mg 5 ml
10 11 ampoule EV 1 mg 10 ml
11 110 cpr riv 100 mg
12 810 mg
13 1100 cps 10 mg vial
14 2100 mg
15 1100MG
16 310MG
17 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
18 110MG/VIAL
19 312.5MG
20 1120 mg
21 2120MG
22 215 mg
23 115 mg/850 mg
24 3150 mg
25 1150MG
26 215MG
27 115MG/VIAL
28 116 cps 25 mg
29 216 mg
30 216 mg/12.5 mg
31 216MG
32 11MCG
33 11MG
34 11MG/ML
35 22.5 mg
36 12.5MG
37 120 cps 150 mg
38 120 cps 225 mg prolonged release
39 120 cps 300 mg
40 120 cps 450 mg prolonged release
41 520 mg
42 2200 mg
43 1200MG
44 420MG
45 1210 mg
46 1225 mg
47 325 mg
48 1250 mg
49 125MG
50 22MCG/ML
51 22MG
52 130 mg
53 1300 MG
54 5300 mg
55 1300MG
56 232 mg
57 132 mg/12.5 mg
58 132 mg/25 mg
59 332MG
60 1400 mg
61 1400MG
62 1405 mg
63 145 mg
64 2450 mg
65 1450MG
66 14MG
67 45 mg
68 150 MG / ML
69 150 mg
70 150 mg/ml
71 1500 mg
72 1500 mg + 400 iu
73 3500MG
74 1500MG/VIAL
75 150MG
76 250MG/ML
77 150MG/VIAL
78 45MG
79 15MG/ML
80 16.25 mg
81 16.3MG
82 17.5 mg
83 17.5MG
84 28 mg
85 180 mg
86 18MG
87 1EQ 100MG BASE/VIAL
88 1EQ 210MG BASE/VIAL
89 1EQ 300MG BASE/VIAL
90 1EQ 405MG BASE/VIAL
91 1EQ 450MG BASE
92 1EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
01 36Canada
02 58Italy
03 15Norway
04 2Sweden
05 33USA
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : ONE-ALPHA
Dosage Strength : 0.25MCG
Packaging :
Approval Date :
Application Number : 474517
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : ONE-ALPHA
Dosage Strength : 1MCG
Packaging :
Approval Date :
Application Number : 474525
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : DROPS
Brand Name : ONE-ALPHA
Dosage Strength : 2MCG/ML
Packaging :
Approval Date :
Application Number : 2240329
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : ONE-ALPHA
Dosage Strength : 2MCG/ML
Packaging :
Approval Date :
Application Number : 2242502
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : POWDER FOR SOLUTION
Brand Name : FUNGIZONE
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date :
Application Number : 29149
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER, METERED;INHALATI...
Brand Name : PULMICORT FLEXHALER
Dosage Strength : 0.08MG/INH
Packaging :
Approval Date : 2006-07-12
Application Number : 21949
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER, METERED;INHALATI...
Brand Name : PULMICORT FLEXHALER
Dosage Strength : 0.16MG/INH
Packaging :
Approval Date : 2006-07-12
Application Number : 21949
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : SUPREFACT
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number : 2225166
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : IMPLANT
Brand Name : SUPREFACT DEPOT 2 MONTHS
Dosage Strength : 6.3MG
Packaging : 2 IMPLANTS
Approval Date :
Application Number : 2228955
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Italy
Calcium carbonate; Cholecalciferol
Dosage Form : Tablet
Brand Name : OROTRE
Dosage Strength : 500 mg + 400 iu
Packaging : 60 UNITS 500 MG + 400 IU - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
LOOKING FOR A SUPPLIER?
